These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26659092)

  • 21. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyper-IgE Syndrome due to an Elusive Novel Intronic Homozygous Variant in DOCK8.
    Tangye SG; Gray PE; Pillay BA; Yap JY; Figgett WA; Reeves J; Kummerfeld SK; Stoddard J; Uzel G; Jing H; Su HC; Campbell DE; Sullivan A; Burnett L; Peake J; Ma CS
    J Clin Immunol; 2022 Jan; 42(1):119-129. PubMed ID: 34657245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients.
    Momtazmanesh S; Rayzan E; Zoghi S; Shahkarami S; Molatefi R; Mohammadzadeh I; Ghaffari J; Mahmoudi H; Dmytrus J; Segarra-Roca A; Somekh I; Witzel M; Hauck F; Boztug K; Klein C; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2022; 22(1):159-168. PubMed ID: 33634762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH
    J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition].
    Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O
    Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficient T Cell Receptor Excision Circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening.
    Dasouki M; Okonkwo KC; Ray A; Folmsbeel CK; Gozales D; Keles S; Puck JM; Chatila T
    Clin Immunol; 2011 Nov; 141(2):128-32. PubMed ID: 21763205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-year follow-up of a DOCK8-deficient child with features of systemic lupus erythematosus.
    Jouhadi Z; Khadir K; Ailal F; Bouayad K; Nadifi S; Engelhardt KR; Grimbacher B
    Pediatrics; 2014 Nov; 134(5):e1458-63. PubMed ID: 25332498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
    Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
    Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic alterations compromised molecular diagnosis of DOCK8 hyper-IgE syndrome caused by a novel intronic splice site mutation.
    Hagl B; Spielberger BD; Thoene S; Bonnal S; Mertes C; Winter C; Nijman IJ; Verduin S; Eberherr AC; Puel A; Schindler D; Ruland J; Meitinger T; Gagneur J; Orange JS; van Gijn ME; Renner ED
    Sci Rep; 2018 Nov; 8(1):16719. PubMed ID: 30425284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency.
    Al-Zahrani D; Raddadi A; Massaad M; Keles S; Jabara HH; Chatila TA; Geha R
    Clin Immunol; 2014 Jul; 153(1):104-108. PubMed ID: 24743019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exome-first Approach Identified Novel Homozygous Dedicator of Cytokinesis 8 (DOCK8) Mutations in Three Unrelated Iranian Pedigrees Suspected with Hyper-IgE Syndrome.
    Aghebati-Maleki A; Shahani T; Momen T; Alyasin S; Changi-Ashtiani M; Biglari A; Shahrooei M; Javanian AS; Amini S; Bossuyt X; Rokni-Zadeh H
    Iran J Allergy Asthma Immunol; 2020 Apr; 19(2):193-199. PubMed ID: 32372632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, immunological and molecular profiles of DOCK8 deficiency in six patients from a tertiary care centre in North India.
    Kumar Jindal A; Sil A; Aggarwal R; Tyagi R; Mondal S; Singh A; Barman P; Chawla S; Loganathan SK; Gupta K; Vinay K; Mahajan R; Saikia B; Kaur G; Sharma R; Saka R; Bhatia A; Sankhyan N; Pandiarajan V; Pilania R; Dhaliwal M; Sharma S; Vyas S; Suri D; Rawat A; Singh S
    Clin Exp Dermatol; 2024 Feb; 49(3):226-234. PubMed ID: 37815217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients.
    Pillay BA; Avery DT; Smart JM; Cole T; Choo S; Chan D; Gray PE; Frith K; Mitchell R; Phan TG; Wong M; Campbell DE; Hsu P; Ziegler JB; Peake J; Alvaro F; Picard C; Bustamante J; Neven B; Cant AJ; Uzel G; Arkwright PD; Casanova JL; Su HC; Freeman AF; Shah N; Hickstein DD; Tangye SG; Ma CS
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31021819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DOCK8 Deficiency Presenting as an IPEX-Like Disorder.
    Alroqi FJ; Charbonnier LM; Keles S; Ghandour F; Mouawad P; Sabouneh R; Mohammed R; Almutairi A; Chou J; Massaad MJ; Geha RS; Baz Z; Chatila TA
    J Clin Immunol; 2017 Nov; 37(8):811-819. PubMed ID: 29058101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome.
    Zhang Q; Davis JC; Dove CG; Su HC
    Dis Markers; 2010; 29(3-4):131-9. PubMed ID: 21178272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
    Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
    Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients.
    Eken A; Cansever M; Okus FZ; Erdem S; Nain E; Azizoglu ZB; Haliloglu Y; Karakukcu M; Ozcan A; Devecioglu O; Aksu G; Arikan Ayyildiz Z; Topal E; Karakoc Aydiner E; Kiykim A; Metin A; Cipe F; Kaya A; Artac H; Reisli I; Guner SN; Uygun V; Karasu G; Dönmez Altuntas H; Canatan H; Oukka M; Ozen A; Chatila TA; Keles S; Baris S; Unal E; Patiroglu T
    Allergy; 2020 Apr; 75(4):921-932. PubMed ID: 31596517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
    Deng Y; Li T; Xie X; Xia D; Ding L; Xiang H; Ma JJ; Li W
    Medicine (Baltimore); 2019 Feb; 98(6):e14003. PubMed ID: 30732127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined immunodeficiency associated with DOCK8 mutations.
    Zhang Q; Davis JC; Lamborn IT; Freeman AF; Jing H; Favreau AJ; Matthews HF; Davis J; Turner ML; Uzel G; Holland SM; Su HC
    N Engl J Med; 2009 Nov; 361(21):2046-55. PubMed ID: 19776401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.